Search hospitals > South Carolina > Charleston
Roper Hospital
Claim this profileCharleston, South Carolina 29401
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
83 reported clinical trials
10 medical researchers
Summary
Roper Hospital is a medical facility located in Charleston, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Roper Hospital is involved with conducting 83 clinical trials across 186 conditions. There are 10 research doctors associated with this hospital, such as David Ellison, Michael Field, M.D., Jacobo Mintzer, MD, and Daniel D. Kirchoff.Area of expertise
1Cancer
Global LeaderStage II
Stage III
Stage IV
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
David EllisonCharleston Hematology Oncology Associates CHOA2 years of reported clinical research
Studies Prostate Cancer
Studies Breast Cancer
3 reported clinical trials
9 drugs studied
Michael Field, M.D.Medical University of South Carolina6 years of reported clinical research
Studies Heart Failure
Studies Atrial Fibrillation
4 reported clinical trials
5 drugs studied
Jacobo Mintzer, MDSouth Carolina Institute for Brain Health5 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
3 reported clinical trials
4 drugs studied
Daniel D. KirchoffBon Secours Saint Francis Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Pancreatic Cancer
2 reported clinical trials
8 drugs studied
Clinical Trials running at Roper Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Pancreatic Cancer
Tumors
Blood Cancers
Pancreatic Cyst
Bleeding
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Roper Hospital?
Roper Hospital is a medical facility located in Charleston, South Carolina. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Roper Hospital is involved with conducting 83 clinical trials across 186 conditions. There are 10 research doctors associated with this hospital, such as David Ellison, Michael Field, M.D., Jacobo Mintzer, MD, and Daniel D. Kirchoff.